Technical Analysis for PROG - Progenity, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Historical PROG trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Signal Line Cross | Bearish | -3.10% | |
Stochastic Reached Oversold | Weakness | -3.10% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
1.5x Volume Pace | about 3 hours ago |
Down 3% | about 3 hours ago |
Rose Above Lower Bollinger Band | about 6 hours ago |
Down 2 % | about 6 hours ago |
Down 1% | about 6 hours ago |
Get this analysis on your stocks daily!
- Earnings date: ???
Progenity, Inc. Description
Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Disease Genomics Drug Delivery In Vitro Precision Medicine Systems Biology Proteomics Systems Science
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 15.92 |
52 Week Low | 3.08 |
Average Volume | 436,112 |
200-Day Moving Average | 6.80 |
50-Day Moving Average | 5.11 |
20-Day Moving Average | 4.52 |
10-Day Moving Average | 4.44 |
Average True Range | 0.42 |
ADX | 20.92 |
+DI | 15.53 |
-DI | 31.71 |
Chandelier Exit (Long, 3 ATRs ) | 3.88 |
Chandelier Exit (Short, 3 ATRs ) | 4.97 |
Upper Bollinger Band | 5.26 |
Lower Bollinger Band | 3.79 |
Percent B (%b) | -0.03 |
BandWidth | 32.54 |
MACD Line | -0.25 |
MACD Signal Line | -0.20 |
MACD Histogram | -0.0526 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.17 | ||||
Resistance 3 (R3) | 4.21 | 4.10 | 4.10 | ||
Resistance 2 (R2) | 4.10 | 4.00 | 4.09 | 4.08 | |
Resistance 1 (R1) | 3.93 | 3.93 | 3.88 | 3.89 | 4.05 |
Pivot Point | 3.82 | 3.82 | 3.80 | 3.81 | 3.82 |
Support 1 (S1) | 3.65 | 3.72 | 3.60 | 3.61 | 3.45 |
Support 2 (S2) | 3.54 | 3.65 | 3.53 | 3.42 | |
Support 3 (S3) | 3.37 | 3.54 | 3.40 | ||
Support 4 (S4) | 3.33 |